1
/
of
1
PI3K-IN-31 [CAS 1359956-12-9]
PI3K-IN-31 [CAS 1359956-12-9]
SKU:QM-0147950-01
£212.81 GBP
Quantity
Couldn't load pickup availability
Request quote or documents
![PI3K-IN-31 [CAS 1359956-12-9]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
PI3K-IN-31 (Compound 6b) is a potent PI3K inhibitor with IC50s of 3.7 nM, 74 nM, 14.6 nM, and 9.9 nM for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, respectively. PI3K-IN-31 has anticancer effects[1].
-
CAS Number
[1359956-12-9]
-
Molecular Formula
C19H23F2N7O3
-
Molecular Weight
435.43
-
Smiles
FC(C1=NC2=CC=CC=C2N1C3=NC(N4CCOCC4)=NC(N(CCO)CCO)=N3)F
-
Target
PI3K
-
Isoform
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
-
Purity
99.33
-
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
-
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
-
Shipping Conditions
Room Temperature
Related Products
- QM-0015916 Wee1/HDAC-IN-1 [CAS 3037071-29-4]
- QM-0013795-01 Vizenpistat [CAS 2687222-58-6]
- QM-0008932 VEGFR-IN-7 [CAS 683235-33-8]
- QM-0008931 VEGFR-IN-6 [CAS 683235-34-9]
- QM-0008885 VEGFR/PDGFR-IN-1 [CAS 342785-98-2]
- QM-0008364-01 Verubecestat (Standard) [CAS 1286770-55-5]
- QM-0007272 Zavondemstat (sodium) [CAS 2908753-07-9]
- QM-0002491-01 Ziritaxestat (Standard) [CAS 1628260-79-6]
- QM-0002017 Zabadinostat (Standard) [CAS 934828-12-3]
- QM-0079654-01 Zabadinostat [CAS 934828-12-3]
Other industry favorites
- QM-0015916 Wee1/HDAC-IN-1 [CAS 3037071-29-4]
- QM-0013795-01 Vizenpistat [CAS 2687222-58-6]
- QM-0154836-01 Verdiperstat [CAS 890655-80-8]
- QM-0142135-01 Virstatin [CAS 88909-96-0]
- QM-0081849-01 Vorinostat (Standard) [CAS 149647-78-9]
- QM-0070505 VEGFR2-IN-3 [CAS 417717-09-0]
- QM-0081529-01 Ziritaxestat [CAS 1628260-79-6]
- QM-0205620-01 VEGFR-3/FLT4, Mouse (HEK293, hFc)
- QM-0178627-01 VinylMyristate (stabilizedwithMEHQ) [CAS 5809-91-6]
- QM-0175073-01 [Nle8] Somatostatin (1-28) (TFA)
PI3K-IN-31 [CAS 1359956-12-9]
PI3K-IN-31 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.